Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00754-20
Full Text
Open PDFAbstract
Available in full text
Date
April 20, 2020
Authors
Publisher
American Society for Microbiology